Heron Therapeutics (HRTX) PT Lowered to $16 at Needham & Company on Financial Overhang Concerns

March 1, 2022 6:31 AM

Needham & Company analyst Serge Belanger lowered the price target on Heron Therapeutics (NASDAQ: HRTX) to $16.00 (from $24.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found